Pegylated Liposomal Doxorubicin Containing Chemotherapy in the Treatment of Older Non-Hodgkin's Lymphoma Patients

This study has been terminated.
(slow accrual)
Sponsor:
Collaborator:
Tibotec Pharmaceutical Limited
Information provided by:
Geriatric Oncology Consortium
ClinicalTrials.gov Identifier:
NCT00120198
First received: July 8, 2005
Last updated: November 15, 2007
Last verified: November 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: September 2006
  Estimated Primary Completion Date: No date given